dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorUniversidade de São Paulo (USP)
dc.date.accessioned2014-05-27T11:18:00Z
dc.date.available2014-05-27T11:18:00Z
dc.date.created2014-05-27T11:18:00Z
dc.date.issued1995-01-17
dc.identifierPharmacology Biochemistry and Behavior, v. 50, n. 1, p. 35-40, 1995.
dc.identifier0091-3057
dc.identifierhttp://hdl.handle.net/11449/64589
dc.identifier10.1016/0091-3057(94)00236-C
dc.identifierWOS:A1995QA54700006
dc.identifier2-s2.0-0028799567
dc.identifier2514762545280942
dc.identifier0000-0002-1378-6327
dc.description.abstractFencamfamine (FCF) is a psychostimulant classified as an indirect dopamine agonist. The conditioning place preference (CPP) paradigm was used to investigate the reinforcing properties of FCF. After initial preferences had been determined, animals were conditioned with FCF (1.75, 3.5, or 7.0 mg/kg; IP). Only at the dose of 3.5 mg/kg FCF produced a significant place preference. Pretreatment with SCH23390 (0.05 mg/kg, SC) or naloxone (1.0 mg/kg SC) 10 min before FCF (3.5 mg/kg; IP) blocked both FCF-induced hyperactivity and CPP. Pretreatment with metoclopramide (10.0 mg/kg; IP) or pimozide (1.0 mg/kg, IP), respectively, 30 min or 4 h before FCF (3.5 mg/kg; IP), which blocked the FCF-induced locomotor activity, failed to influence place conditioning produced by FCF. In conclusion, the present study suggests that dopamine D 1 and opioid receptors are related to FCF reinforcing effect, while dopamine D 2 subtype receptor was ineffective in modifying FCF-induced CPP.
dc.languageeng
dc.relationPharmacology Biochemistry and Behavior
dc.relation2.538
dc.relation1,150
dc.rightsAcesso restrito
dc.sourceScopus
dc.subjectDopamine receptors
dc.subjectFencamfamine
dc.subjectOpioid receptors
dc.subjectPlace conditioning
dc.subjectReinforcement
dc.subject8 chloro 2,3,4,5 tetrahydro 3 methyl 5 phenyl 1h 3 benzazepin 7 ol hydrogen maleate
dc.subjectdopamine 1 receptor
dc.subjectdopamine 2 receptor
dc.subjectdopamine receptor
dc.subjectdopamine receptor stimulating agent
dc.subjectfencamfamin
dc.subjectmetoclopramide
dc.subjectnaloxone
dc.subjectopiate receptor
dc.subjectpimozide
dc.subjectpsychostimulant agent
dc.subjectreceptor subtype
dc.subjectanimal experiment
dc.subjectconditioning
dc.subjectcontrolled study
dc.subjectdrug antagonism
dc.subjecthyperactivity
dc.subjectintraperitoneal drug administration
dc.subjectnonhuman
dc.subjectplace preference
dc.subjectpriority journal
dc.subjectrat
dc.subjectreinforcement
dc.subjectsubcutaneous drug administration
dc.subjectAnimal
dc.subjectBinding, Competitive
dc.subjectCentral Nervous System Stimulants
dc.subjectConditioning, Operant
dc.subjectMetoclopramide
dc.subjectNaloxone
dc.subjectNorbornanes
dc.subjectPimozide
dc.subjectRats
dc.subjectReceptors, Dopamine D1
dc.subjectReceptors, Dopamine D2
dc.subjectReceptors, Opioid, mu
dc.subjectReinforcement (Psychology)
dc.subjectSch-23390
dc.subjectAnimalia
dc.titleReinforcing properties of fencamfamine: Involvement of dopamine and opioid receptors
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución